Lumacaftor/ivacaftor combination for CF patients homozygous for Phe508del-CFTR

Cystic Fibrosis (CF) is a life-shortening inherited disease caused by the loss or dysfunction of the CF transmembrane conductance regulator (CFTR) channel activity resulting from mutations in the CFTR gene. Phe508del is the most prevalent mutation with approximately 90% of CF patients carries it on...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Drugs Today (Barc)
Päätekijät: Zhang, Weiqiang, Zhang, Xiaoying, Zhang, Yanhui H., Stokes, Dennis C, Naren, Anjaparavanda P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5495103/
https://ncbi.nlm.nih.gov/pubmed/27252987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1358/dot.2016.52.4.2467205
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia